XML 76 R65.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Thousands
6 Months Ended
Jul. 01, 2017
Jul. 02, 2016
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations $ 711 $ 7,731
Net cash used in operating activities of discontinued operations 0 (10,296)
Net cash provided by (used in) operating activities 711 (2,565)
Cash flows from investing activities:    
Capital expenditures (14,478) (17,561)
Proceeds from sale of property, plant and equipment 1,265 7,993
Proceeds from sale of assets 0 2,000
Net cash used in investing activities of continuing operations (13,213) (7,568)
Net cash provided by investing activities of discontinued operations 0 92,906
Net cash (used in) provided by investing activities (13,213) 85,338
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021 0 50,000
Payment of financing-related costs and expenses and debt issuance discounts (298) (10,763)
Proceeds from issuance of other long-term debt 7,900 0
Repayments of other long-term debt (2,978) (3,102)
Repayment of 11.5% senior notes due 2017 (20,465) (4,725)
Repayment of 7% senior exchangeable notes due 2017 (5,493) (27,580)
Purchase and retirement of common stock upon vesting of restricted stock units (55) (341)
Borrowings under asset-based revolving credit facility due 2021 221,253 247,100
Repayments under asset-based revolving credit facility due 2021 (185,945) (339,400)
Intercompany advances 0 0
Net cash provided by (used in) financing activities of continuing operations 13,919 (88,811)
Net cash used in financing activities of discontinued operations 0 (8)
Net cash provided by (used in) financing activities 13,919 (88,819)
Effect of exchange rate changes on cash and cash equivalents 149 453
Net increase (decrease) in cash and cash equivalents 1,566 (5,593)
Cash and cash equivalents at beginning of period 5,532 10,556
Cash and cash equivalents at end of period 7,098 4,963
Parent Company [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations   1,008
Net cash used in operating activities of discontinued operations   0
Net cash provided by (used in) operating activities 435 1,008
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of property, plant and equipment 0 0
Proceeds from sale of assets   0
Net cash used in investing activities of continuing operations   0
Net cash provided by investing activities of discontinued operations   0
Net cash (used in) provided by investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt 0  
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0 0
Purchase and retirement of common stock upon vesting of restricted stock units (55) (341)
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (380) (667)
Net cash provided by (used in) financing activities of continuing operations   (1,008)
Net cash used in financing activities of discontinued operations   0
Net cash provided by (used in) financing activities (435) (1,008)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Subsidiary Issuer [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations   (56,001)
Net cash used in operating activities of discontinued operations   0
Net cash provided by (used in) operating activities (38,254) (56,001)
Cash flows from investing activities:    
Capital expenditures (9,258) (8,559)
Proceeds from sale of property, plant and equipment 1,265 7,973
Proceeds from sale of assets   0
Net cash used in investing activities of continuing operations   (586)
Net cash provided by investing activities of discontinued operations   0
Net cash (used in) provided by investing activities (7,993) (586)
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   50,000
Payment of financing-related costs and expenses and debt issuance discounts (298) (10,763)
Proceeds from issuance of other long-term debt 7,900  
Repayments of other long-term debt (4,162) (3,352)
Repayment of 11.5% senior notes due 2017 (20,465) (4,725)
Repayment of 7% senior exchangeable notes due 2017 (5,493) (27,580)
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 221,253 247,100
Repayments under asset-based revolving credit facility due 2021 (185,945) (339,400)
Intercompany advances 37,860 143,669
Net cash provided by (used in) financing activities of continuing operations   54,949
Net cash used in financing activities of discontinued operations   0
Net cash provided by (used in) financing activities 50,650 54,949
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 4,403 (1,638)
Cash and cash equivalents at beginning of period 4,678 5,558
Cash and cash equivalents at end of period 9,081 3,920
Guarantor Subsidiaries [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations   61,624
Net cash used in operating activities of discontinued operations   (9,858)
Net cash provided by (used in) operating activities 37,842 51,766
Cash flows from investing activities:    
Capital expenditures (4,688) (8,565)
Proceeds from sale of property, plant and equipment 0 20
Proceeds from sale of assets   2,000
Net cash used in investing activities of continuing operations   (6,545)
Net cash provided by investing activities of discontinued operations   86,419
Net cash (used in) provided by investing activities (4,688) 79,874
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt 0  
Repayments of other long-term debt 1,184 250
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0 0
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (36,856) (135,130)
Net cash provided by (used in) financing activities of continuing operations   (134,880)
Net cash used in financing activities of discontinued operations   (8)
Net cash provided by (used in) financing activities (35,672) (134,888)
Effect of exchange rate changes on cash and cash equivalents 149 316
Net increase (decrease) in cash and cash equivalents (2,369) (2,932)
Cash and cash equivalents at beginning of period 0 3,006
Cash and cash equivalents at end of period (2,369) 74
Non-Guarantor Subsidiaries [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations   1,100
Net cash used in operating activities of discontinued operations   (438)
Net cash provided by (used in) operating activities 688 662
Cash flows from investing activities:    
Capital expenditures (532) (437)
Proceeds from sale of property, plant and equipment 0 0
Proceeds from sale of assets   0
Net cash used in investing activities of continuing operations   (437)
Net cash provided by investing activities of discontinued operations   6,487
Net cash (used in) provided by investing activities (532) 6,050
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt 0  
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0 0
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (624) (7,872)
Net cash provided by (used in) financing activities of continuing operations   (7,872)
Net cash used in financing activities of discontinued operations   0
Net cash provided by (used in) financing activities (624) (7,872)
Effect of exchange rate changes on cash and cash equivalents 0 137
Net increase (decrease) in cash and cash equivalents (468) (1,023)
Cash and cash equivalents at beginning of period 854 1,992
Cash and cash equivalents at end of period 386 969
Eliminations [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations   0
Net cash used in operating activities of discontinued operations   0
Net cash provided by (used in) operating activities 0 0
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of property, plant and equipment 0 0
Proceeds from sale of assets   0
Net cash used in investing activities of continuing operations   0
Net cash provided by investing activities of discontinued operations   0
Net cash (used in) provided by investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt 0  
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0 0
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances 0 0
Net cash provided by (used in) financing activities of continuing operations   0
Net cash used in financing activities of discontinued operations   0
Net cash provided by (used in) financing activities 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0